BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Jan. 27, 2016
View Archived Issues
Firm finds niche in cardiovascular monitoring: Irhythm finds its groove in both wearable, digital health markets
Read More
Hold placed on Califf nomination: Senate hostage-taking snares confirmation of FDA head
Read More
Ebola Lessons learned? Global organizations to speed Zika R&D
Read More
Financings: Minnetronix dips its toe in equity market with $20M raise
Read More
People in Places
Read More
Daily M&A: Perkinelmer completes acquisition of Vanadis
Read More
Agreements/contracts: Stereotaxis, Philips to continue cardiology procedure work
Read More
product briefs
Read More
Briefly noted
Read More
MDD's Oncology Extra
Read More
Funding to be used for host of trials: Cancer genomics firm Inivata pulls in $42M in series A funding
LONDON – Inivata Ltd. has raised £31.5 million (US$42.2 million) in a series A round, to advance the commercialization of its circulating tumor DNA liquid biopsy technology.
Read More
Inside the Beltway: NICE offers favorable review of AMS's Greenlight for BPH
Read More
